Dear List members
I have today mailed to all 51 UK NEQAS participants who use AxSYM for
progesterone an information pack comprising:
(1) a letter summarising the situation and offering assistance
(2) a response form to collect information on when the affected
batches were used
(3) a table of results for AxSYM and all other major methods for the
last year
(4) a summary of the statistical relationship for UK NEQAS results
between AxSYM and other major methods to help evaluate any changes in
results when other methods are used.
I can make this information available to non-UK NEQAS participant
clinical laboratories using Abbott AxSYM for progesterone on written
request to the address below. The request must describe the purpose
for which the information is required.
This information has also gone to Abbott UK.
I hope this helps
Jonathan Middle - Organiser UK NEQAS for steroid hormones.
Jonathan Middle PhD, Chairman UK NEQAS Executive,
UK NEQAS, PO Box 3909, Birmingham B15 2UE, U.K.
tel +44 (0)121 414 7300, fax +44 (0)121 414 1179
[log in to unmask] http://www.ukneqas.org.uk
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|